Peritoneal dialysis (PD) has several advantages compared to haemodialysis (HD), but there
is evidence showing underutilization globally, especially in low‐income and lower‐middle …

The prevalence of kidney failure continues to rise globally. Dialysis is a treatment option for
individuals with kidney failure; after the decision to initiate dialysis has been made, it is …

Purpose Cardiovascular disease is a significant cause of morbidity and mortality in dialysis
patients. With the increasing prevalence of dialysis patients, there is a need to systematically …

Aim: Renal replacement therapy was primary treatment for end stage kidney (ESRD)
patients. Numbers of studies comparing peritoneal dialysis (PD) and hemodialysis (HD) …

Aims Mineralocorticoid receptor antagonists (MRAs) have been shown to provide survival
benefits in patients with heart failure; however, MRA use in patients with chronic kidney …

The practice and clinical outcomes of peritoneal dialysis (PD) have demonstrated significant
improvement over the past 20 years. The aim of this review is to increase awareness and …

Background End-stage kidney disease (ESKD) substantially impacts different aspects of
patients' lives, including mental and physical health, and overall quality of life. The aim of our …

Abstract Rationale & Objective Mortality is an important outcome for all dialysis stakeholders.
We examined associations between dialysis modality and mortality in the modern era. Study …

The increasing prevalence of diabetes has led to a growing population of end-stage kidney
disease (ESKD) patients with diabetes. Currently, kidney transplantation is the best …

Background and objectives: Survival of peritoneal dialysis (PD) patients in Japan is high, but
few reports exist on cause-specific mortality, transfer to haemodialysis (HD) or hybrid …